Final results from a Phase 3, long‐term, open‐label, repeat‐dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy

OBJECTIVE: A Phase 3 open‐label safety study (NCT02721069) evaluated long‐term safety of diazepam nasal spray (Valtoco) in patients with epilepsy and frequent seizure clusters. METHODS: Patients were 6–65 years old with diagnosed epilepsy and seizure clusters despite stable antiseizure medications....

Descripción completa

Detalles Bibliográficos
Autores principales: Wheless, James W., Miller, Ian, Hogan, R. Edward, Dlugos, Dennis, Biton, Victor, Cascino, Gregory D., Sperling, Michael R., Liow, Kore, Vazquez, Blanca, Segal, Eric B., Tarquinio, Daniel, Mauney, Weldon, Desai, Jay, Rabinowicz, Adrian L., Carrazana, Enrique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Full‐length Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290500/
https://www.ncbi.nlm.nih.gov/pubmed/34418086
http://dx.doi.org/10.1111/epi.17041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290500/
https://www.ncbi.nlm.nih.gov/pubmed/34418086
http://dx.doi.org/10.1111/epi.17041

Ejemplares similares